Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.（CLDX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CLDX · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
4
近12个月
买卖比
0.25
Buy/Sell (by trades)
整体情绪
Celldex Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CLDX 季度内部人买卖趋势
CLDX 内幕交易卖出 · CLDX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CLDX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CLDX 高管卖出股份 · CLDX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jan 2, 2026 | Martin Samuel Bates SVP AND CFO | Option | 4,817 | $50K | Form 4 |
| Dec 15, 2025 | PEPIN RONALD SR. VP & CBO | Option | 11,000 | $31K | Form 4 |
| Dec 15, 2025 | PEPIN RONALD SR. VP & CBO | Option | 8,333 | $75K | Form 4 |
| Dec 4, 2025 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | 4,166 | $121K | Form 4 |
| Nov 13, 2025 | Wright Richard M. other: Former Officer | Option | 15,750 | $354K | Form 4 |
| Nov 13, 2025 | Wright Richard M. other: Former Officer | Option | 26,672 | $277K | Form 4 |
| Nov 13, 2025 | Wright Richard M. other: Former Officer | Option | 6,876 | $62K | Form 4 |
| Nov 13, 2025 | Wright Richard M. other: Former Officer | Sale | 49,298 | $1.18M⚡ | Form 4 |
| Aug 13, 2025 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | 341 | $8K | Form 4 |
| Aug 13, 2025 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | 430 | $11K | Form 4 |
| Nov 18, 2024 | MARINO JAMES J Director | Gift | 10,500 | — | Form 4 |
| Nov 11, 2024 | Marucci Anthony S PRESIDENT & CEO · Director | Purchase | 11,500 | $308K | Form 4 |
| Jun 14, 2024 | Martin Samuel Bates SVP AND CFO | Option | 16,968 | $176K | Form 4 |
| Jun 14, 2024 | Martin Samuel Bates SVP AND CFO | Option | 3,201 | $29K | Form 4 |
| Jun 14, 2024 | Martin Samuel Bates SVP AND CFO | Sale | 17,172 | $608K | Form 4 |
| Jun 14, 2024 | Crowley Elizabeth SR. VP & CPDO | Option | 30,000 | $311K | Form 4 |
| Jun 14, 2024 | Crowley Elizabeth SR. VP & CPDO | Sale | 30,000 | $1.05M⚡ | Form 4 |
| Jun 11, 2024 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Option | 15,000 | $41K | Form 4 |
| Jun 7, 2024 | Crowley Elizabeth SR. VP & CPDO | Option | 7,500 | $68K | Form 4 |
| Jun 7, 2024 | Crowley Elizabeth SR. VP & CPDO | Option | 7,500 | $78K | Form 4 |
| Jun 7, 2024 | Crowley Elizabeth SR. VP & CPDO | Sale | 15,000 | $526K | Form 4 |
| Jun 7, 2024 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Sale | 45,000 | $1.59M⚡ | Form 4 |
| Jun 5, 2024 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option | 9,540 | $99K | Form 4 |
| Jun 3, 2024 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Option | 58,369 | $606K | Form 4 |
| Jun 3, 2024 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Sale | 58,369 | $1.96M⚡ | Form 4 |
Marucci Anthony S
PRESIDENT & CEO · Director
日期
Nov 11
股数
11,500
均价
$26.82
总金额
$308K
Young Diane C.
SVP, CHIEF MEDICAL OFFICER
日期
Jun 7
股数
45,000
均价
$35.26
总金额
$1.59M ⚡
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
日期
Jun 3
股数
58,369
均价
$10.38
总金额
$606K
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
日期
Jun 3
股数
58,369
均价
$33.65
总金额
$1.96M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CLDX 内幕交易
CLDX 内幕交易
Celldex Therapeutics, Inc.（CLDX）内幕交易数据来源于公司内部人（包括Wright Richard M. (other: Former Officer), Jimenez Freddy A. (SVP & GENERAL COUNSEL), PEPIN RONALD (SR. VP & CBO)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。CLDX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Celldex Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CLDX 内幕交易 · 5个问题Celldex Therapeutics, Inc.（CLDX）的内部人包括高管和董事，如Wright Richard M. (other: Former Officer), Jimenez Freddy A. (SVP & GENERAL COUNSEL), PEPIN RONALD (SR. VP & CBO)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026